REGENERON PHARMACEUTICALS, INC. Insider Trading for May 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. for May 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 29 2020 | REGN | REGENERON PHARMACE ... | Sanofi | Sell | S | 509.85 | 2,399,552 | 1,223,411,587 | 400,000 | 2.8 M to 400 K (-85.71 %) | |
May 29 2020 | REGN | REGENERON PHARMACE ... | Sanofi | Sell | S | 509.85 | 20,421,899 | 10,412,105,205 | 0 | 20.4 M to 0 (-100.00 %) | |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 30.63 | 77,309 | 2,367,975 | 0 | |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 30.63 | 77,309 | 2,367,975 | 77,309 | |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 30.63 | 77,309 | 2,367,975 | 154,618 | |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 30.63 | 77,309 | 2,367,975 | 231,927 | |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 30.63 | 3,264 | 99,976 | 0 | |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 433 | 0 | 143,900 | 144.3 K to 143.9 K (-0.30 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 564 | 0 | 144,333 | 144.9 K to 144.3 K (-0.39 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 578.34 | 100 | 57,834 | 307,749 | 307.8 K to 307.7 K (-0.03 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 577.37 | 683 | 394,344 | 307,849 | 308.5 K to 307.8 K (-0.22 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 576.47 | 206 | 118,753 | 308,532 | 308.7 K to 308.5 K (-0.07 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 575.34 | 2,606 | 1,499,336 | 308,738 | 311.3 K to 308.7 K (-0.84 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 574.69 | 2,622 | 1,506,837 | 311,344 | 314 K to 311.3 K (-0.84 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 573.55 | 2,610 | 1,496,966 | 313,966 | 316.6 K to 314 K (-0.82 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 572.69 | 1,356 | 776,568 | 316,576 | 317.9 K to 316.6 K (-0.43 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 571.32 | 2,877 | 1,643,688 | 317,932 | 320.8 K to 317.9 K (-0.90 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 570.60 | 2,049 | 1,169,159 | 320,809 | 322.9 K to 320.8 K (-0.63 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 569.40 | 3,232 | 1,840,301 | 322,858 | 326.1 K to 322.9 K (-0.99 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 568.43 | 11,447 | 6,506,818 | 326,090 | 337.5 K to 326.1 K (-3.39 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 567.51 | 9,138 | 5,185,906 | 337,537 | 346.7 K to 337.5 K (-2.64 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 566.42 | 14,548 | 8,240,278 | 346,675 | 361.2 K to 346.7 K (-4.03 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 565.47 | 12,996 | 7,348,848 | 361,223 | 374.2 K to 361.2 K (-3.47 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 564.62 | 13,268 | 7,491,378 | 374,219 | 387.5 K to 374.2 K (-3.42 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 563.53 | 11,551 | 6,509,335 | 387,487 | 399 K to 387.5 K (-2.89 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 562.48 | 8,359 | 4,701,770 | 399,038 | 407.4 K to 399 K (-2.05 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 561.40 | 10,418 | 5,848,665 | 407,397 | 417.8 K to 407.4 K (-2.49 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 560.45 | 12,456 | 6,980,965 | 417,815 | 430.3 K to 417.8 K (-2.89 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 559.51 | 8,826 | 4,938,235 | 430,271 | 439.1 K to 430.3 K (-2.01 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 558.36 | 11,168 | 6,235,764 | 439,097 | 450.3 K to 439.1 K (-2.48 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 557.51 | 5,910 | 3,294,884 | 450,265 | 456.2 K to 450.3 K (-1.30 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 556.79 | 1,168 | 650,331 | 456,175 | 457.3 K to 456.2 K (-0.26 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Payment of Exercise | F | 570.97 | 39,720 | 22,678,928 | 457,343 | 497.1 K to 457.3 K (-7.99 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 30.63 | 77,309 | 2,367,975 | 497,063 | 419.8 K to 497.1 K (+18.42 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Payment of Exercise | F | 570.97 | 39,974 | 22,823,955 | 419,754 | 459.7 K to 419.8 K (-8.70 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 30.63 | 77,309 | 2,367,975 | 459,728 | 382.4 K to 459.7 K (+20.22 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Payment of Exercise | F | 570.97 | 39,974 | 22,823,955 | 382,419 | 422.4 K to 382.4 K (-9.46 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 30.63 | 77,309 | 2,367,975 | 422,393 | 345.1 K to 422.4 K (+22.40 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Payment of Exercise | F | 570.97 | 39,974 | 22,823,955 | 345,084 | 385.1 K to 345.1 K (-10.38 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 30.63 | 77,309 | 2,367,975 | 385,058 | 307.7 K to 385.1 K (+25.12 %) |
May 22 2020 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 30.63 | 3,264 | 99,976 | 307,749 | 304.5 K to 307.7 K (+1.07 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | M | 30.63 | 187,500 | 5,743,125 | 0 | |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | M | 30.63 | 125,000 | 3,828,750 | 187,500 | |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 577.27 | 638 | 368,298 | 474,499 | 475.1 K to 474.5 K (-0.13 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 576.51 | 1,728 | 996,209 | 475,137 | 476.9 K to 475.1 K (-0.36 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 575.48 | 2,196 | 1,263,754 | 476,865 | 479.1 K to 476.9 K (-0.46 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 574.59 | 4,390 | 2,522,450 | 479,061 | 483.5 K to 479.1 K (-0.91 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 573.27 | 10,014 | 5,740,726 | 483,451 | 493.5 K to 483.5 K (-2.03 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 572.47 | 19,984 | 11,440,240 | 493,465 | 513.4 K to 493.5 K (-3.89 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 571.49 | 15,542 | 8,882,098 | 513,449 | 529 K to 513.4 K (-2.94 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 570.49 | 20,267 | 11,562,121 | 528,991 | 549.3 K to 529 K (-3.69 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 569.52 | 19,982 | 11,380,149 | 549,258 | 569.2 K to 549.3 K (-3.51 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 568.58 | 18,021 | 10,246,380 | 569,240 | 587.3 K to 569.2 K (-3.07 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 567.57 | 9,359 | 5,311,888 | 587,261 | 596.6 K to 587.3 K (-1.57 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 566.51 | 5,810 | 3,291,423 | 596,620 | 602.4 K to 596.6 K (-0.96 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 565.67 | 3,032 | 1,715,111 | 602,430 | 605.5 K to 602.4 K (-0.50 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 564.41 | 779 | 439,675 | 605,462 | 606.2 K to 605.5 K (-0.13 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 563.51 | 2,549 | 1,436,387 | 606,241 | 608.8 K to 606.2 K (-0.42 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 562.75 | 1,394 | 784,474 | 608,790 | 610.2 K to 608.8 K (-0.23 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 561.24 | 3,994 | 2,241,593 | 610,184 | 614.2 K to 610.2 K (-0.65 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 560.68 | 3,391 | 1,901,266 | 614,178 | 617.6 K to 614.2 K (-0.55 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 559.52 | 1,361 | 761,507 | 617,569 | 618.9 K to 617.6 K (-0.22 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 558.35 | 4,162 | 2,323,853 | 618,930 | 623.1 K to 618.9 K (-0.67 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 557.51 | 2,329 | 1,298,441 | 623,092 | 625.4 K to 623.1 K (-0.37 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Payment of Exercise | F | 571.43 | 96,947 | 55,398,424 | 625,421 | 722.4 K to 625.4 K (-13.42 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Buy | M | 30.63 | 187,500 | 5,743,125 | 722,368 | 534.9 K to 722.4 K (+35.06 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Payment of Exercise | F | 571.43 | 64,631 | 36,932,092 | 534,868 | 599.5 K to 534.9 K (-10.78 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Buy | M | 30.63 | 125,000 | 3,828,750 | 599,499 | 474.5 K to 599.5 K (+26.34 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | M | 33.42 | 5,000 | 167,100 | 7,500 | |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 575.00 | 300 | 172,500 | 8,700 | 9 K to 8.7 K (-3.33 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 575.00 | 300 | 172,500 | 3,400 | 3.7 K to 3.4 K (-8.11 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 575.00 | 250 | 143,750 | 2,150 | 2.4 K to 2.2 K (-10.42 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 580.00 | 5,000 | 2,900,000 | 115,415 | 120.4 K to 115.4 K (-4.15 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Buy | M | 33.42 | 5,000 | 167,100 | 120,415 | 115.4 K to 120.4 K (+4.33 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | M | 30.63 | 187,500 | 5,743,125 | 0 | |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | M | 30.63 | 125,000 | 3,828,750 | 187,500 | |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 577.27 | 638 | 368,298 | 474,499 | 475.1 K to 474.5 K (-0.13 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 576.51 | 1,728 | 996,209 | 475,137 | 476.9 K to 475.1 K (-0.36 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 575.48 | 2,196 | 1,263,754 | 476,865 | 479.1 K to 476.9 K (-0.46 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 574.59 | 4,390 | 2,522,450 | 479,061 | 483.5 K to 479.1 K (-0.91 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 573.27 | 10,014 | 5,740,726 | 483,451 | 493.5 K to 483.5 K (-2.03 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 572.47 | 19,984 | 11,440,240 | 493,465 | 513.4 K to 493.5 K (-3.89 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 571.49 | 15,542 | 8,882,098 | 513,449 | 529 K to 513.4 K (-2.94 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 570.49 | 20,267 | 11,562,121 | 528,991 | 549.3 K to 529 K (-3.69 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 569.52 | 19,982 | 11,380,149 | 549,258 | 569.2 K to 549.3 K (-3.51 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 568.58 | 18,021 | 10,246,380 | 569,240 | 587.3 K to 569.2 K (-3.07 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 567.57 | 9,359 | 5,311,888 | 587,261 | 596.6 K to 587.3 K (-1.57 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 566.51 | 5,810 | 3,291,423 | 596,620 | 602.4 K to 596.6 K (-0.96 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 565.67 | 3,032 | 1,715,111 | 602,430 | 605.5 K to 602.4 K (-0.50 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 564.41 | 779 | 439,675 | 605,462 | 606.2 K to 605.5 K (-0.13 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 563.51 | 2,549 | 1,436,387 | 606,241 | 608.8 K to 606.2 K (-0.42 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 562.75 | 1,394 | 784,474 | 608,790 | 610.2 K to 608.8 K (-0.23 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 561.24 | 3,994 | 2,241,593 | 610,184 | 614.2 K to 610.2 K (-0.65 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 560.68 | 3,391 | 1,901,266 | 614,178 | 617.6 K to 614.2 K (-0.55 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 559.52 | 1,361 | 761,507 | 617,569 | 618.9 K to 617.6 K (-0.22 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 558.35 | 4,162 | 2,323,853 | 618,930 | 623.1 K to 618.9 K (-0.67 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 557.51 | 2,329 | 1,298,441 | 623,092 | 625.4 K to 623.1 K (-0.37 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Payment of Exercise | F | 571.43 | 96,947 | 55,398,424 | 625,421 | 722.4 K to 625.4 K (-13.42 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Buy | M | 30.63 | 187,500 | 5,743,125 | 722,368 | 534.9 K to 722.4 K (+35.06 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Payment of Exercise | F | 571.43 | 64,631 | 36,932,092 | 534,868 | 599.5 K to 534.9 K (-10.78 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Buy | M | 30.63 | 125,000 | 3,828,750 | 599,499 | 474.5 K to 599.5 K (+26.34 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | M | 33.42 | 5,000 | 167,100 | 7,500 | |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 575.00 | 300 | 172,500 | 8,700 | 9 K to 8.7 K (-3.33 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 575.00 | 300 | 172,500 | 3,400 | 3.7 K to 3.4 K (-8.11 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 575.00 | 250 | 143,750 | 2,150 | 2.4 K to 2.2 K (-10.42 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 580.00 | 5,000 | 2,900,000 | 115,415 | 120.4 K to 115.4 K (-4.15 %) |
May 13 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Buy | M | 33.42 | 5,000 | 167,100 | 120,415 | 115.4 K to 120.4 K (+4.33 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Option Exercise | M | 52.03 | 52,500 | 2,731,575 | 0 | |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Option Exercise | M | 52.03 | 33,079 | 1,721,100 | 52,500 | |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 569.42 | 700 | 398,594 | 28,251 | 29 K to 28.3 K (-2.42 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 568.57 | 3,040 | 1,728,453 | 28,951 | 32 K to 29 K (-9.50 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 567.35 | 3,753 | 2,129,265 | 31,991 | 35.7 K to 32 K (-10.50 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 566.47 | 7,297 | 4,133,532 | 35,744 | 43 K to 35.7 K (-16.95 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 565.49 | 5,984 | 3,383,892 | 43,041 | 49 K to 43 K (-12.21 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 564.54 | 3,000 | 1,693,620 | 49,025 | 52 K to 49 K (-5.77 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 563.58 | 2,195 | 1,237,058 | 52,025 | 54.2 K to 52 K (-4.05 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 562.45 | 2,077 | 1,168,209 | 54,220 | 56.3 K to 54.2 K (-3.69 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 561.55 | 4,988 | 2,801,011 | 56,297 | 61.3 K to 56.3 K (-8.14 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 560.53 | 3,231 | 1,811,072 | 61,285 | 64.5 K to 61.3 K (-5.01 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 559.20 | 500 | 279,600 | 64,516 | 65 K to 64.5 K (-0.77 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 558.43 | 2,118 | 1,182,755 | 65,016 | 67.1 K to 65 K (-3.15 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 557.59 | 600 | 334,554 | 67,134 | 67.7 K to 67.1 K (-0.89 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Sell | S | 556.92 | 100 | 55,692 | 67,734 | 67.8 K to 67.7 K (-0.15 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Payment of Exercise | F | 555.77 | 28,217 | 15,682,162 | 67,834 | 96.1 K to 67.8 K (-29.38 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Buy | M | 52.03 | 52,500 | 2,731,575 | 96,051 | 43.6 K to 96.1 K (+120.55 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Payment of Exercise | F | 555.77 | 17,779 | 9,881,035 | 43,551 | 61.3 K to 43.6 K (-28.99 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Buy | M | 52.03 | 33,079 | 1,721,100 | 61,330 | 28.3 K to 61.3 K (+117.09 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Option Exercise | M | 177.82 | 15,000 | 2,667,300 | 0 | |
May 08 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 566.01 | 100 | 56,601 | 1,830 | 1.9 K to 1.8 K (-5.18 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 565.35 | 900 | 508,815 | 1,930 | 2.8 K to 1.9 K (-31.80 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 564.45 | 6,600 | 3,725,370 | 2,830 | 9.4 K to 2.8 K (-69.99 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 563.45 | 6,375 | 3,591,994 | 9,430 | 15.8 K to 9.4 K (-40.34 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 562.65 | 1,025 | 576,716 | 15,805 | 16.8 K to 15.8 K (-6.09 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Buy | M | 177.82 | 15,000 | 2,667,300 | 16,830 | 1.8 K to 16.8 K (+819.67 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Option Exercise | M | 391.92 | 5,118 | 2,005,847 | 10,235 | |
May 08 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 569.20 | 13 | 7,400 | 643 | 656 to 643 (-1.98 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 568.37 | 609 | 346,137 | 656 | 1.3 K to 656 (-48.14 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 567.58 | 646 | 366,657 | 1,265 | 1.9 K to 1.3 K (-33.80 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 566.37 | 2,128 | 1,205,235 | 1,911 | 4 K to 1.9 K (-52.69 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 565.64 | 1,722 | 974,032 | 4,039 | 5.8 K to 4 K (-29.89 %) |
May 08 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Buy | M | 391.92 | 5,118 | 2,005,847 | 5,761 | 643 to 5.8 K (+795.96 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | M | 520.01 | 9,212 | 4,790,332 | 0 | |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | M | 413.33 | 10,838 | 4,479,671 | 0 | |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | M | 380.95 | 4,960 | 1,889,512 | 2,479 | |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | M | 376.69 | 7,830 | 2,949,483 | 0 | |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | M | 371.40 | 3,784 | 1,405,378 | 0 | |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | M | 273.67 | 8,500 | 2,326,195 | 0 | |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | M | 177.82 | 5,000 | 889,100 | 0 | |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 556.31 | 4,731 | 2,631,903 | 28,843 | 33.6 K to 28.8 K (-14.09 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 555.25 | 1,595 | 885,624 | 33,574 | 35.2 K to 33.6 K (-4.54 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 554.33 | 2,172 | 1,204,005 | 35,169 | 37.3 K to 35.2 K (-5.82 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 553.16 | 5,423 | 2,999,787 | 37,341 | 42.8 K to 37.3 K (-12.68 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 552.33 | 6,477 | 3,577,441 | 42,764 | 49.2 K to 42.8 K (-13.15 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 551.66 | 7,341 | 4,049,736 | 49,241 | 56.6 K to 49.2 K (-12.97 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 550.58 | 7,295 | 4,016,481 | 56,582 | 63.9 K to 56.6 K (-11.42 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 549.35 | 4,113 | 2,259,477 | 63,877 | 68 K to 63.9 K (-6.05 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 548.17 | 2,597 | 1,423,597 | 67,990 | 70.6 K to 68 K (-3.68 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 547.37 | 1,597 | 874,150 | 70,587 | 72.2 K to 70.6 K (-2.21 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 546.31 | 1,631 | 891,032 | 72,184 | 73.8 K to 72.2 K (-2.21 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 545.34 | 1,390 | 758,023 | 73,815 | 75.2 K to 73.8 K (-1.85 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 544.57 | 405 | 220,551 | 75,205 | 75.6 K to 75.2 K (-0.54 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 543.12 | 1,260 | 684,331 | 75,610 | 76.9 K to 75.6 K (-1.64 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 542.66 | 496 | 269,159 | 76,870 | 77.4 K to 76.9 K (-0.64 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 541.66 | 1,600 | 866,656 | 77,366 | 79 K to 77.4 K (-2.03 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 556.62 | 1 | 557 | 78,966 | 79 K to 79 K (0.00 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Buy | M | 177.82 | 5,000 | 889,100 | 78,967 | 74 K to 79 K (+6.76 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Buy | M | 273.67 | 8,500 | 2,326,195 | 73,967 | 65.5 K to 74 K (+12.98 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Buy | M | 413.33 | 10,838 | 4,479,671 | 65,467 | 54.6 K to 65.5 K (+19.84 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Buy | M | 520.01 | 9,212 | 4,790,332 | 54,629 | 45.4 K to 54.6 K (+20.28 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Buy | M | 376.69 | 7,830 | 2,949,483 | 45,417 | 37.6 K to 45.4 K (+20.83 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Buy | M | 380.95 | 4,960 | 1,889,512 | 37,587 | 32.6 K to 37.6 K (+15.20 %) |
May 07 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Buy | M | 371.40 | 3,784 | 1,405,378 | 32,627 | 28.8 K to 32.6 K (+13.12 %) |
May 06 2020 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 560.00 | 2,000 | 1,120,000 | 7,643 | 9.6 K to 7.6 K (-20.74 %) |
May 04 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 528.78 | 1 | 529 | 28,843 | 28.8 K to 28.8 K (0.00 %) |
May 04 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 527.44 | 1 | 527 | 28,844 | 28.8 K to 28.8 K (0.00 %) |
May 04 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 524.39 | 6 | 3,146 | 28,845 | 28.9 K to 28.8 K (-0.02 %) |
May 04 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 523.36 | 1 | 523 | 28,851 | 28.9 K to 28.9 K (0.00 %) |
May 04 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 522.61 | 7 | 3,658 | 28,852 | 28.9 K to 28.9 K (-0.02 %) |
May 04 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 521.36 | 17 | 8,863 | 28,859 | 28.9 K to 28.9 K (-0.06 %) |
May 04 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 520.46 | 22 | 11,450 | 28,876 | 28.9 K to 28.9 K (-0.08 %) |
May 04 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 519.54 | 18 | 9,352 | 28,898 | 28.9 K to 28.9 K (-0.06 %) |
May 04 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 518.57 | 15 | 7,779 | 28,916 | 28.9 K to 28.9 K (-0.05 %) |
May 04 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 517.41 | 12 | 6,209 | 28,931 | 28.9 K to 28.9 K (-0.04 %) |